Victoria Nachar
@VictoriaNachar
Followers
460
Following
3K
Media
42
Statuses
1K
Hematology Clinical Pharmacist @UMRogelCancer 〽️#GoBills #Buffalove
Ann Arbor, MI
Joined June 2011
✨ DREAMS DO COME TRUE ✨ Thank you @ratemyskyperoom
3
6
186
10/ #ASH25 Abstract 720: 1st-line CRS Tx with dex in #MMsm bsAbs (McElwee @thisisJamesD et al) "Pocket dex": equal efficacy, way cheaper / simpler than toci, albeit >1 dose more likely. This makes outpt bsAb SUD *way* easier for pts. As I now say: #Downwithdex
#ExceptforCRS !
2
3
11
Check out our latest episode, "Chill for 5: The Febrile Neutropenia Survival Guide"! Plus find out why @ajperissinotti was laughing at @Berninini for wearing this ridiculous tuque ❄️#wolverheme #leusm
https://t.co/2FPsr5qbqC
2
5
12
We're BACK after a summer break! Listen to our latest episode "Prophy and Pints"! Let us de-mystify antimicrobial prophylaxis and help you choose the best regimen for your patients! 🦠💊 @Berninini @ajperissinotti
open.spotify.com
WolverHeme Happy Hour · Episode
1
4
12
Dexamethasone for the management of CRS Related to teclistamab in patients with relapsed/refractory multiple myeloma | Blood Cancer Journal
nature.com
Blood Cancer Journal - Dexamethasone for the management of CRS Related to teclistamab in patients with relapsed/refractory multiple myeloma
1
8
34
Me, in my car. Well done @WolverHeme
🔔We had to convene an emergency meeting with @dgermain21 and @ManniMD1 just for this episode ‼️ "ODAC - Our Decisions Are Confusing" @ajperissinotti @Berninini
https://t.co/TiIEIIff5p
0
2
5
Check out are latest episode, with a star-studded cast! 🤩 "Dex and the Cytokine City: Managing CRS with Bispecifics" #leusm #lymsm #myeloma #TwitteRx @berninini @thisisJamesD @VictoriaNachar @ajperissinotti @PharmacistOnc
creators.spotify.com
In this episode, Bernie and Anthony are joined by 3 hematology pharmacists - James Davis, PharmD, BCOP; Victoria Nachar, PharmD, BCOP; and Justine Preedit, PharmD, BCOP - to discuss the optimal...
0
15
28
📘 Dive into BCMA-directed therapies for MM and strengthen your treatment approach with new data! 📍 Oregon Convention Center, 777 NE Martin Luther King Jr Blvd, Room B113-114 📢 Learn more: https://t.co/dKGQkKHRoR Join 👉 @KirollosPharmD @VictoriaNachar @jayinabox
#HOPA2025
0
2
2
Myeloma Paper of the Day, March 5th, suggested by Robert Orlowski (@Myeloma_Doc) @VictoriaNachar @kczmj
https://t.co/X65tXxSYBk
#MyelomaPaperoftheDay #OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc #MedNews
oncodaily.com
Myeloma Paper of the Day, March 5th, suggested by Robert Orlowski / cancer, James Davis, Jordan Snyder, Mikhaila Rice, Myeloma Paper of the Day, OncoDaily,
0
1
14
🌶️Hot off the press! 🌶️ Dexamethasone for CRS with teclistamab. You don't need toci for grade 1 CRS! great team work - @VictoriaNachar @CWagnerPharmD @kczmj @KLratermann @MikhailaPharmD @KG_PharmD @khouri_jack
https://t.co/lxpTdhkQie
3
26
110
HOPA's OCC, with the participation of @ASCO Quality Training Programs, has developed practice-based tools to aid in developing and improving initiatives and the care of patients receiving oral anticancer agents (OAAs). Read the full article @JCO_ASCO: https://t.co/1PNjB3D4dx
1
3
7
How do you treat low grade CRS due to myeloma bispecifics? We investigated differences of using dexamethasone and toci in CRS with teclistamab in six US centers and found as few as one 10mg dex dose is enough to alleviate low grade CRS. #ASH24 @VictoriaNachar @kczmj @j_snyder0132
3
11
54
Time for a MANTLE CELL MASTERCLASS with @LymphClinician @ajperissinotti and @Berninini ! Should TRIANGLE change the SOC? Where do bispecifics and CAR-T fit into the treatment paradigm? Listen and find out! #lymsm #twitterx
creators.spotify.com
In this episode, Tycel Phillips, MD joins Anthony and Bernie to discuss updates in Mantle Cell Lymphoma, including the TRIANGLE study and the recently published results of glofitamab in R/R MCL....
3
13
63
Bispecific antibodies are changing treatment in Hem/Onc.. but adoption has been mixed due to logistics! Out now in @JADPRO, we aim to tackle some FAQ! 🙏🏻 to @amirsali101 @thisisJamesD @SandahlTyler @VictoriaNachar @KPsiBCOP! #oncopharm #TwitterRx
jadpro.com
Bispecific antibodies (BsAbs) have emerged as crucial therapeutic agents; however, multidisciplinary collaboration is essential to ensure optimal patient outcomes amid operational complexities. Read...
2
12
47
Join us!
We’re 1 week away from our virtual webinar on the evolving landscape of #myelofibrosiscare. Leading pharmacists @VictoriaNachar, @JustinArnall1 will discuss: ✅ Key considerations for managed care professionals ✅ Varied roles of pharmacists Register: https://t.co/bPqoYKTsGZ
0
4
7
Check out our latest episode "Myeloma Madness with the Myeloma Man", where @ajperissinotti and @Berninini discuss the recent FDA approval updates on CAR-T in myeloma with our good friend and myeloma expert @ManniMD1
creators.spotify.com
In this episode, Anthony and Bernie are joined by Multiple Myeloma expert Dr. Manni Mohyuddin, to discuss the recent FDA approval updates of CAR-T in this disease state. We also discuss the hotly...
3
15
54
Managed care professionals looking to stay updated on the latest in #myelofibrosiscare. Join our CPE-certified webinar with @VictoriaNachar, @JustinArnall1. Learn about treatment advances & pharmacist roles in patient care. 👉 Add it to your calendar: https://t.co/bPqoYKSURr
0
1
1
Great Peer Exchange with an amazing group on myelofibrosis with @thisisJamesD @kczmj @VictoriaNachar and Shawn Griffin https://t.co/NolpMKy4A1
pharmacytimes.com
Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA, and a panel of pharmacists explore pharmacist roles in myelofibrosis care, treatment challenges, patient outcomes, and pharmacist responsibilities...
0
4
11
Dual target dilemma lead by the incredible @thisisJamesD
#epcoritamab vs #glofitamab battle of the bispecifics. hopefully the first of many collabs with @VictoriaNachar 👏🤓😎 #lymsm #oncopharm
2
2
20
The Taylor swift references - incredible. Literally 10/10. Chefs kiss. 🤌@ajperissinotti @Berninini @maddyochs @JustinArnall1
Newest episode is out! Join #teambadblood🩸as we go our own Eras Tour of Hemophilia treatment! @JustinArnall1 @maddyochs @Berninini @ajperissinotti #classicalhematology #itsnotbenign
0
2
10
What’s cooler than being cool? Being Maddy Ochs that’s what! Great talk on cold agglutinin disease by the rockstar @maddyochs #HOPAAC23
1
1
20